NYSE · BMY
Bristol-Myers Squibb Company
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for BMY has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $1.21 | $1.75 | $1.01 | 9 |
| Dec 2026 | $1.63 | $1.72 | $1.53 | 8 |
| Mar 2027 | $1.47 | $1.60 | $1.31 | 4 |
| Jun 2027 | $1.77 | $2.07 | $1.61 | 4 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · RTTNews · The Motley Fool- Zacks · Oct 29, 8:30 AM EDTHere's What Key Metrics Tell Us About Bristol Myers (BMY) Q3 EarningsThe headline numbers for Bristol Myers (BMY) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- Zacks · Oct 29, 7:35 AM EDTBristol Myers Squibb (BMY) Q3 Earnings and Revenues Beat EstimatesBristol Myers (BMY) delivered earnings and revenue surprises of +11.57% and +4.07%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Oct 29, 7:29 AM EDTBristol-Myers Squibb Slashes FY26 EPS Outlook, But Raises Revenue Forecast – Update(RTTNews) – While reporting financial results for the third quarter on Thursday, Bristol-Myers Squibb Co. (BMY) slashed its earnings guidance for the full-year 2026, while raising annual revenue outlook.
- RTTNews · Oct 29, 7:09 AM EDTBristol Myers Squibb Co. Q3 Income Retreats(RTTNews) – Bristol Myers Squibb Co. (BMY) released a profit for third quarter that Drops, from the same period last year
- RTTNews · Oct 29, 7:04 AM EDTBristol Myers Squibb Q3 26 Earnings Conference Call At 8:00 AM ET(RTTNews) – Bristol Myers Squibb Co. (BMY) will host a conference call at 8:00 AM ET on Oct 29, 2026, to discuss Q3 26 earnings results.
- The Motley Fool · Oct 28, 11:35 AM EDT3 Magnificent Dividend Stocks for Risk-Averse InvestorsConsumer goods giant Procter & Gamble’s sheer size is a proven competitive edge.
- Zacks · Oct 28, 10:26 AM EDTPfizer Stock Ahead of Q3 Earnings: To Buy or Not to Buy?Pfizer heads into Q3 earnings with strong drug sales and an attractive valuation, but declining COVID revenues and looming patent expirations pose challenges.
- RTTNews · Oct 28, 3:02 AM EDTCardiff Names Alland Interim Medical Chief Ahead Of Planned Phase 3 Cancer Trial(RTTNews) – Shares of Cardiff Oncology, Inc. (CRDF) fell 5.70% in after-hours trading on Tuesday after the clinical-stage biotechnology company announced Leila Alland's appointment as interim chief medical officer (CMO).
- Zacks · Oct 27, 9:47 AM EDTWhat's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings?Biotech earnings take center stage as Bristol Myers, Eli Lilly, Merck, AbbVie and Gilead Sciences prepare to report Q3'26 results.
- Zacks · Oct 27, 9:00 AM EDTAnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?AnaptysBio (ANAB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- The Motley Fool · Oct 27, 2:33 AM EDTBristol Myers Squibb’s Cancer Drug Just Doubled Survival Time Without Progression — Here’s Why It MattersIt also demonstrated very promising results when evaluated in other solid tumors.
- The Motley Fool · Oct 26, 3:35 PM EDT3 Cheap Dividend Stocks I'd Buy Without Any HesitationBristol Myers Squibb doesn’t bring any drama-driven volatility to the table — just what you want right now.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Bristol-Myers Squibb Company from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.